Surface Expression of CD28 Single Chain Fv for Costimulation by Tumor Cells

This publication has 19 references indexed in Scilit:

• A reassessment of the role of B7-1 expression in tumor rejection.
  The Journal of Experimental Medicine, 1995
• CTLA-4 can function as a negative regulator of T cell activation
  Immunity, 1994
• Binding of phosphatidyl-inositol-3-OH kinase to CD28 is required for T-cell signalling
  Nature, 1994
• The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3'-kinase.
  Molecular and Cellular Biology, 1994
• Stimulation of CD28 triggers an association between CD28 and phosphatidylinositol 3-kinase in Jurkat T cells.
  The Journal of Experimental Medicine, 1994
• Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity.
  The Journal of Experimental Medicine, 1994
• Transgenic plants expressing a functional single-chain Fv antibody are specifically protected from virus attack
  Nature, 1993
• Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules.
  Proceedings of the National Academy of Sciences, 1993
• Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
  Cell, 1992
• CTLA-4 is a second receptor for the B cell activation antigen B7.
  The Journal of Experimental Medicine, 1991